Rabies vaccine inactivated (VRVg) - Sanofi

Drug Profile

Rabies vaccine inactivated (VRVg) - Sanofi

Alternative Names: Purified Vero Rabies Vaccine - Sanofi; Rabies VRVg; VerorabVax; VRVg 1; VRVg 2

Latest Information Update: 15 Feb 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Developer Sanofi
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Rabies

Most Recent Events

  • 31 Jul 2018 Sanofi announces intention to submit regulatory application for Rabies in 2022
  • 05 Jan 2018 Sanofi completes a phase II trial for Rabies (In volunteers) in USA (NCT03145766)
  • 06 Jun 2017 No recent reports on development identified - Preregistration for Rabies (Prevention) in China (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top